Hims & Hers Health Inc (HIMS) Technical Analysis
$51.99▲1.15%
Market is closed - opens 7 PM, 12 May 2025
Insights
- Hims & Hers Health is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Hims & Hers Health stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Hims & Hers Health stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Hims & Hers Health stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 75.49 | Sell |
Stochastic | 90.68, 93.09 | Sell |
Ultimate Oscillator | 74.13 | Sell |
Stochastic Relative Strength Index | 96.55, 98.21 | Sell |
Moving Average Convergence Divergence | 5.08, 2.3 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 42.07 | Buy |
20 | 34.7 | Buy |
50 | 33.84 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 43.81 | Buy |
20 | 38.59 | Buy |
50 | 35.62 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 42.66 | Buy |
20 | 39.93 | Buy |
50 | 37.05 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 51.18 | Buy |
20 | 44.32 | Buy |
50 | 36.89 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 54.26 | Buy |
20 | 49.89 | Buy |
50 | 38.27 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 58.8 |
Resistance L2 | 56.77 |
Resistance L1 | 54.09 |
Pivot Point | 52.06 |
Support L1 | 49.38 |
Support L2 | 47.35 |
Support L3 | 44.67 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.